General information
The Rare disease (RD) field benefits from national and international multidisciplinary collaborations to face the challenges in research. Access to infrastructures, collaborative research and policy platforms, virtual platforms for data integration are some examples of means to overcome bottlenecks for diagnosis and treatment of RD patients. Biosamples managing is not an exception. The scarcity of biosamples for every RD and the risk of knowledge siloing or information duplication may be overcome by the strengthening of collaboration and dynamism of biosamplesโ circuits including participation of all the stakeholders, to shorten the way and time from bench to bedside.